LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 24.89 | 771.67 | 1635 | 2397 | 0.6819 | 0.5826 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 27.11 | 771.67 | 1356 | 2675 | 0.5069 | 0.3693 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 27.11 | 771.67 | 1663 | 2675 | 0.6217 | 0.5343 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 29.33 | 771.67 | 1349 | 2939 | 0.4589 | 0.3358 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 29.33 | 771.67 | 1667 | 2939 | 0.5671 | 0.4906 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 31.55 | 771.67 | 1350 | 3196 | 0.4223 | 0.3136 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 31.55 | 771.67 | 1673 | 3196 | 0.5233 | 0.4584 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.78 | 771.67 | 1370 | 3499 | 0.3915 | 0.3011 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.78 | 771.67 | 1648 | 3499 | 0.4709 | 0.4161 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.00 | 771.67 | 1416 | 3884 | 0.3645 | 0.2974 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.00 | 771.67 | 1659 | 3884 | 0.4271 | 0.3885 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.22 | 771.67 | 1363 | 4299 | 0.3170 | 0.2581 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.22 | 771.67 | 1659 | 4299 | 0.3859 | 0.3619 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 40.44 | 771.67 | 1363 | 4738 | 0.2877 | 0.2427 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 40.44 | 771.67 | 1656 | 4738 | 0.3495 | 0.3386 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.67 | 771.67 | 1373 | 5155 | 0.2663 | 0.2340 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.67 | 771.67 | 1679 | 5155 | 0.3257 | 0.3281 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 44.89 | 771.67 | 1388 | 5541 | 0.2505 | 0.2293 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 44.89 | 771.67 | 1662 | 5541 | 0.2999 | 0.3096 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 47.11 | 771.67 | 1424 | 5941 | 0.2397 | 0.2313 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 47.11 | 771.67 | 1663 | 5941 | 0.2799 | 0.2979 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 49.33 | 771.67 | 1410 | 6392 | 0.2206 | 0.2185 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 49.33 | 771.67 | 1661 | 6392 | 0.2598 | 0.2857 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 51.55 | 771.67 | 1445 | 6829 | 0.2116 | 0.2207 | MN20160304_L01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 51.55 | 771.67 | 1697 | 6829 | 0.2485 | 0.2847 | MN20160304_L01 | K06 |